Bitcoin trades above $100,000 with stable momentum as MVRV Z-Score signals sustainability. Cooling ratios and institutional demand show a healthier market cycle.
Litecoin shows indecisive moves but holds a bullish falling wedge against Bitcoin. LTCBTC consolidates near record lows, with stabilization signs emerging.
Bitcoin trades above $100,000 with stable momentum as MVRV Z-Score signals sustainability. Cooling ratios and institutional demand show a healthier market cycle.
Litecoin shows indecisive moves but holds a bullish falling wedge against Bitcoin. LTCBTC consolidates near record lows, with stabilization signs emerging.
Bitcoin trades above $100,000 with stable momentum as MVRV Z-Score signals sustainability. Cooling ratios and institutional demand show a healthier market cycle.
Litecoin shows indecisive moves but holds a bullish falling wedge against Bitcoin. LTCBTC consolidates near record lows, with stabilization signs emerging.
Bitcoin trades above $100,000 with stable momentum as MVRV Z-Score signals sustainability. Cooling ratios and institutional demand show a healthier market cycle.
Litecoin shows indecisive moves but holds a bullish falling wedge against Bitcoin. LTCBTC consolidates near record lows, with stabilization signs emerging.
Pineapple Financial’s $100M Digital Asset Treasury strategy on Injective drives institutional momentum as PAPL volumes surge and INJ consolidates near $14, eyeing a breakout above $14.50.
Bitcoin nears a potential breakout as it tests key resistance around $110K, while altcoins like VeChain, Injective, Arbitrum, and Peaq show renewed strength
Injective Protocol (INJ) shows signs of a bullish reversal as whale accumulation, strong support zones, and technical indicators align for a potential 30–35% price surge.
INJ remains range-bound with $10 support and $16.15 resistance.
Coinbase's quiet accumulation signals institutional confidence in Injective.
Injective (INJ) is at...
INJ’s inverse head and shoulders pattern confirms a bullish breakout.
Trading volume rose over 36%, showing strong investor market interest.
Injective...